Form 8-K - Current report:
SEC Accession No. 0001104659-25-051841
Filing Date
2025-05-22
Accepted
2025-05-22 08:00:45
Documents
16
Period of Report
2025-05-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2515845d1_8k.htm   iXBRL 8-K 65532
2 EXHIBIT 2.1 tm2515845d1_ex2-1.htm EX-2.1 533825
3 EXHIBIT 10.1 tm2515845d1_ex10-1.htm EX-10.1 15101
4 EXHIBIT 10.2 tm2515845d1_ex10-2.htm EX-10.2 30590
8 GRAPHIC tm2515845d1_ex10-1img01.jpg GRAPHIC 3651
  Complete submission text file 0001104659-25-051841.txt   948369

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA hook-20250521.xsd EX-101.SCH 3029
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE hook-20250521_lab.xml EX-101.LAB 34239
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hook-20250521_pre.xml EX-101.PRE 22368
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2515845d1_8k_htm.xml XML 3829
Mailing Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

EIN.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38869 | Film No.: 25974756
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)